| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022196861 |
| P356 | DOI | 10.1186/2049-6958-5-2-84 |
| P932 | PMC publication ID | 3463092 |
| P698 | PubMed publication ID | 22958780 |
| P5875 | ResearchGate publication ID | 230836166 |
| P2093 | author name string | Arzu Yorgancioglu | |
| Aylin Ozgen Alpaydin | |||
| Aysın Sakar Coskun | |||
| Beyhan Cengiz Ozyurt | |||
| Nurhan Sarioglu | |||
| Pınar Celik | |||
| P2860 | cites work | A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. | Q47674749 |
| Clinical significance of serum concentration of interleukin 8 in patients with bronchial asthma or chronic pulmonary emphysema. | Q50615939 | ||
| Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. | Q53106078 | ||
| The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). | Q53182496 | ||
| Factor analysis of quality of life, dyspnea, and physiologic variables in patients with chronic obstructive pulmonary disease before and after rehabilitation. | Q53496286 | ||
| Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. | Q54748182 | ||
| Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease | Q61862817 | ||
| Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease | Q61875242 | ||
| Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society | Q68060128 | ||
| A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire | Q68139804 | ||
| Evaluation of clinical methods for rating dyspnea | Q68267114 | ||
| Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis | Q71322663 | ||
| The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes | Q71351694 | ||
| Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease | Q79786400 | ||
| Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity | Q80341374 | ||
| [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases] | Q81275626 | ||
| C-reactive protein levels and clinically important predictive outcomes in stable COPD patients | Q82458910 | ||
| Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 | ||
| How should health-related quality of life be assessed in patients with COPD? | Q33836963 | ||
| ATS Statement | Q34136219 | ||
| Health status measurement in chronic obstructive pulmonary disease | Q34407695 | ||
| Systemic effects in COPD. | Q34523163 | ||
| The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease | Q34546085 | ||
| Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease | Q35533189 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| COPD, a multicomponent disease: implications for management | Q36119043 | ||
| Raised CRP levels mark metabolic and functional impairment in advanced COPD. | Q36148662 | ||
| C-reactive protein in patients with COPD, control smokers and non-smokers | Q36148673 | ||
| Systemic effects of COPD. | Q36283964 | ||
| Interrelationships between inflammation, C-reactive protein, and insulin resistance | Q36902768 | ||
| Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? | Q37252566 | ||
| Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease | Q47244745 | ||
| Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease | Q47286648 | ||
| Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients | Q47338257 | ||
| Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease | Q47366827 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 84-91 | |
| P577 | publication date | 2010-04-30 | |
| P1433 | published in | Multidisciplinary Respiratory Medicine | Q24040391 |
| P1476 | title | Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients | |
| P478 | volume | 5 |
| Q37441610 | Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD. |
| Q36722428 | Markers of lower respiratory tract infections in emergency departments |
| Q60302083 | Post-discharge extended care contributes to the disease control of patients with COPD: a Chinese study |
| Q37623974 | Risk factors for FEV1 decline in mild COPD and high-risk populations |
Search more.